本文へ移動
cccskills
無料GitHub で公開

esa-pa-decide-avs-use

Determines whether to perform adrenal venous sampling (AVS) to lateralize aldosterone excess in patients with confirmed primary aldosteronism (PA) who are being evaluated for surgical treatment. Indicated when surgery is feasible and desired by the patient, or when subtype workup is planned for a surgical candidate, especially in those younger than 35 years with spontaneous hypokalemia, marked aldosterone excess, and unilateral adrenal lesions on CT.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.6 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Determine When to Use Adrenal Venous Sampling for PA

STEP 1 — Gather Information

Confirm PA via positive ARR and confirmatory test; assess blood pressure, serum potassium, age, adrenal CT findings (lesion size, laterality, cortical adenoma features), patient’s surgical candidacy and desire, and current medications (especially MR antagonists). Proceed to assess surgical feasibility and patient preference.

STEP 2 — Rule In / Rule Out

Is surgical treatment feasible and desired by the patient? If yes, proceed to Step 3; if no, recommend medical treatment with an MR antagonist and stop.

STEP 3 — Classify or Stratify

Evaluate for AVS-sparing criteria: age <35 years, spontaneous hypokalemia, marked aldosterone excess (PAC >20 ng/dL), and unilateral adrenal lesion with radiological features of a cortical adenoma on CT. If all criteria are met, AVS may be omitted; otherwise, proceed to recommend AVS.

STEP 4 — Decide

If all AVS-sparing criteria are met, consider proceeding directly to unilateral adrenalectomy without AVS; if any criterion is unmet, recommend AVS to lateralize aldosterone excess.

Clinical Guardrails / Mimics / Pitfalls

Do not perform AVS in patients unwilling or unable to undergo surgery; avoid relying on CT alone for lateralization in patients ≥35 years or with bilateral/hyperplastic adrenal disease; ensure an experienced radiologist conducts AVS to minimize non‑selective sampling and adrenal hemorrhage; withhold AVS in uncontrolled hypertension or coagulopathy until stabilized.

Concrete Clinical Example

A 32‑year‑old woman with hypertension, spontaneous hypokalemia, PAC 30 ng/dL, undetectable renin, and a 1.5 cm left adrenal nodule on CT desires surgery. She meets all AVS‑sparing criteria (<35 y, spontaneous hypokalemia, marked aldosterone excess, unilateral cortical adenoma‑like lesion), so AVS is omitted and she proceeds to laparoscopic left adrenalectomy.

Source: The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, John W. Funder et al., 2016, DOI:10.1210/jc.2015-4061

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する